This bill revises how the annual premium rates for Washington's Paid Family and Medical Leave program are determined, affecting both employers and employees who contribute to and benefit from the program. It changes the process for setting the total premium rate, moving from a specific formula to being based on an annual report from the office of actuarial services. This report must now recommend premium rates designed to maintain the program's solvency for the next four years while limiting rate fluctuations. Additionally, it requires the report to ensure the program closes each rate collection year with a specific three-month reserve by 2030, with the maximum premium rate remaining at 1.20 percent.
SB 5923 creates a new pilot program for critical access hospitals in Skagit County located on islands, allowing them to opt out of standard federal critical access hospital payments. Hospitals participating in this "Washington rural health access preservation pilot" would receive value-based payments focused on quality and essential services (like emergency care) instead of traditional fee-for-service rates. The pilot requires the Department of Health and Health Care Authority to establish alternative payment methods that sustain rural hospital services, with optional participation and reporting requirements to the legislature. It directly affects Skagit County island hospitals certified as critical access hospitals, replacing their standard Medicaid payment structure with the pilot’s methodology.
SB 6014 clarifies Washington's pregnancy accommodation law by limiting when employers can request written medical certification for pregnancy-related adjustments (e.g., modified duties or breaks), except for specific accommodations like lifting restrictions. It prohibits employers from disclosing employees' personal health information related to pregnancy and adds strict confidentiality rules for complaint records filed with the state, protecting names, addresses, and medical details. The bill also requires the state department to provide online education materials explaining pregnancy accommodation rights for employers and employees. These changes directly affect pregnant employees seeking workplace adjustments, employers subject to the law, and state agencies handling complaints.
HB 2254 proposes changes to how mental health program costs are funded in Washington State. It requires health carriers, self-funded health plans, and employers to pay a proportional share of administrative costs for partnership access lines and psychiatric consultation services based on their share of insured residents served by these programs. The bill allows third-party administrators' reasonable costs to be included in the assessment, but excludes the Health Care Authority's own administrative expenses. This would shift some funding responsibility from state budgets to covered health entities while maintaining state funding for programs under Chapter 74.09 RCW.
HB 2340 extends substance use disorder monitoring program protections to nursing assistants who are credentialed under Washington state law. It prohibits public posting of enforcement actions against these professionals if they comply with a board-approved monitoring program. The bill creates a stipend program covering up to 80% of eligible out-of-pocket costs for program participation, including treatment, evaluations, and peer support. Nursing assistants must apply for the stipend, demonstrate financial need, and actively participate in the program to qualify. The board must publicly report program participation and expenses annually.
SB 5915 amends Washington State's health technology assessment program to establish clearer processes for reviewing medical technologies. It requires the committee to prioritize technologies based on Medicare recommendations, safety concerns, high costs, or significant usage variations, and mandates systematic evidence-based assessments from designated federal centers. The bill sets timelines for reviews (180 days for initial assessments) and requires transparency through public comment periods and written explanations for denied requests. It directly affects state health programs (like Medicaid) and providers by determining which medical technologies qualify as covered benefits based on safety, effectiveness, and cost evidence.
HB 2441 requires Washington state to reimburse surviving spouses or domestic partners for medical insurance premiums after a public safety officer or first responder dies "in the course of employment" (as defined by the Department of Labor & Industries). The bill covers premiums for state health plans, Medicare Part A/B, and COBRA insurance, starting from the date of death until the line-of-duty status is confirmed. Survivors must maintain Medicare Part A and B enrollment to qualify for reimbursement, and the reimbursement amount cannot exceed what would be paid under COBRA. This applies only to deaths classified as line-of-duty, not all deaths.
SB 6183 requires most health plans in Washington State to cover all FDA-approved HIV antiviral drugs without prior authorization, step therapy, or other extra approval steps starting January 1, 2027. This directly affects people with HIV who rely on these medications and their health insurers. The law allows plans to restrict coverage for certain drug versions if at least one therapeutically equivalent option is fully covered without hurdles. It applies to all health plans subject to state insurance regulations, ensuring broader access to essential HIV treatment.
HB 2319 renames three state facilities currently referred to as "schools" in statutes to "residential habilitation centers" to better reflect their actual purpose of providing habilitative support (like daily living skills training and medical services) rather than education. Specifically, Fircrest School, Rainier School, and Yakima Valley School become Fircrest Residential Habilitation Center, Rainier Residential Habilitation Center, and Yakima Valley Residential Habilitation Center, respectively, while Lakeland Village retains its existing name. The bill clarifies that these name changes are purely administrative - no services, operations, or funding access will be altered. It also updates related statutes to use the new facility names consistently across state law.
This bill requires most health insurance plans (excluding public employee plans) to cover intravenous immunoglobulin therapy for children diagnosed with PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections) or PANS (pediatric acute-onset neuropsychiatric syndrome) starting January 2027. It mandates coverage for three initial monthly treatment courses and ongoing care as medically necessary, after less intensive treatments fail or aren't tolerated. The law prohibits insurers from denying coverage based on prior treatment history, diagnostic name changes, requiring ineffective symptom-only therapies first, or restricting coverage inconsistent with medical guidelines. It also ensures coverage for out-of-state treatment when local care isn't available.
